DNA THROMBOTIC RISK TEST


DNA THROMBOTIC RISK TEST new york, we love new york

The DNA Thrombotic Risk Test is a genetic test designed to determine if you have an increased risk of developing blood clots, a condition known as thrombophilia. This test examines specific genetic variants that are associated with a higher likelihood of abnormal clotting. Here are some key points:

Key Genes Tested

  1. F5 (Factor V Leiden): A mutation in this gene can increase the risk of deep vein thrombosis (DVT) and other clotting disorders.

  2. F2 (Prothrombin): A mutation in this gene can also elevate the risk of blood clots.

  3. MTHFR: Mutations in this gene can affect homocysteine levels, which can influence clotting risk.

Procedure

  • Sample Collection: The test typically involves a simple buccal swab (cheek swab) to collect DNA.

  • Analysis: The collected DNA is analyzed in a lab to identify the presence of the specific genetic variants.

Benefits

  • Risk Assessment: Helps identify individuals at higher risk for thrombophilia, allowing for early intervention and management.

  • Personalized Care: Provides valuable information for healthcare providers to tailor treatment and preventive measures.

Considerations

  • Genetic Predisposition: Having these genetic variants does not guarantee that you will develop blood clots, but it does indicate a higher risk.

  • Other Factors: Lifestyle, environmental factors, and other health conditions also play a significant role in clotting risk.

Contact DNA Consulta on (00356) 7979 7910 or send an email to novagia@hotmail.com to know more and book a test.. 

< Back to Services